See also this year's filing and all EDGAR filings for this company.
PDF Report 0001261734_2014_Aeolus_Pharmaceuticals_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001261734, Aeolus Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 1,935,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 31,000 |
| 4 | LiabilitiesCurrent | 1,261,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 3,266,000 |
| 9 | ResearchAndDevelopmentExpense | 3,360,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 3,418,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,966,000 |
| 1 | Liabilities | 1,261,000 |
| 2 | Expenses | 6,626,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 705,000 |
| 5 | NetIncome | -3,208,000 |
| 6 | ComprehensiveNetIncome | -3,208,000 |
| 7 | BaseVar | 6,635,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -1.04 |
| 9 | EconomicCapitalRatio | 1.29 |
Edgar->Model Mapping
Feature Distribution
Change over Time
